EDITORIAL: An opportunity for bipartisanship on Medicare drug prices - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
November 24, 2018 Newswires
Share
Share
Post
Email

EDITORIAL: An opportunity for bipartisanship on Medicare drug prices

Press Democrat, The (Santa Rosa, CA)

Nov. 24--Despite bitter partisanship in Washington, politicians of all stripes should agree that reducing Medicare drug costs without harming patient care is a pretty good idea.

One reason for America's high cost of health care is that many medicines are much more expensive here than abroad. In fact, an analysis by the U.S. Department of Health and Human Services found the typical price of Medicare Part B drugs was 80 percent higher in the U.S. than in other industrialized nations.

A report this year from Medicare trustees said parts of the program are heading toward insolvency by 2026. That dismal prospect is three years earlier than previously projected.

The Trump administration wants to bring down those Medicare drug prices, keeping them more in line with prices charged abroad. A similar plan floated by the Obama administration drew fierce opposition and was shelved.

Yet if President Donald Trump is on board and newly empowered Democrats in the House of Representatives really do want to curb rapidly increasing health care costs, this could be an area for bipartisan compromise.

The administration's proposed Medicare model would use the International Pricing Index to limit prices for Medicare Part B drugs that must be administered in doctors' offices or hospitals. These include medications for cancer, arthritis and a host of other diseases. Spending on such Part B drugs has doubled since 2006, according to Health and Human Services.

The Trump administration would phase in that Plan B drug pricing over five years, cutting costs by 30 percent -- a projected savings of $17.2 billion.

In general, Medicare Part B currently reimburses for the average cost of a drug plus 6 percent for the health provider's cost of administering it. Critics say the 106 percent reimbursement creates an incentive to use the most expensive drugs.

Fair enough, but that margin also enables some independent medical practitioners to stay in business.

The challenge is to reform drug pricing in ways that neither stifle competition nor prevent patients from receiving the most effective medications.

In addition, the pharmaceutical companies deserve a reasonable return on their research and development investment. But what is reasonable, and how much of it should come from Americans? Trump contends foreign medical systems are freeloaders, negotiating lower drug prices while Americans wind up subsidizing the drugs' development.

In describing the proposal, Health and Human Services officials said, "This free-market approach seeks the same type of discounts that drug makers already voluntarily negotiate with economically similar countries." Medicare would pay 126 percent of the prices that other countries pay.

Health and Human Services researchers had compared U.S. prices for 27 different Part B drugs with those charged in 16 other countries. Most U.S. prices were higher -- in some cases four times as high.

There are many variables across national lines that limit the validity of these sorts of analyses, but the researchers' bottom line was direct: Higher U.S. prices "mean that the Medicare program pays nearly twice as much as it would pay for the same or similar drugs in other countries."

That reality should galvanize action across party lines. America is as far from national elections as it gets. It's the perfect time for bold measures to control health care costs.

___

(c)2018 The Press Democrat (Santa Rosa, Calif.)

Visit The Press Democrat (Santa Rosa, Calif.) at www.pressdemocrat.com

Distributed by Tribune Content Agency, LLC.

Older

Top Benefits Provided By Online Car Insurance Quotes

Newer

In NC, nonprofits have become the ‘backbone of disaster recovery’

Advisor News

  • Semi-retirement: helping clients balance flexibility with financial security
  • The 6X Formula for leveraging content marketing with AI
  • When a home becomes difficult to insure, the plan changes
  • The inheritance gap: Helping clients plan for money that hasn’t arrived
  • After the midterms: Addressing your clients’ tax concerns
More Advisor News

Annuity News

  • Athene CEO criticizes offshore reinsurance, risk-taking by competitors
  • DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
  • John Hancock launches new fixed indexed annuity suite
  • Annuities to play a larger role in workplace retirement plans
  • FHLBank Pittsburgh Announces Results in 2026 Board Election
More Annuity News

Health/Employee Benefits News

  • Patients with 3 health insurance plans lose access to Miami health network
  • Weld County deputy struggling after being injured by DUI driver (photo gallery)
  • Changes to Medicare Advantage plan offerings affect Montana seniors
  • Medicaid work rules don’t apply to Native Americans. They could still lose coverage.
  • Native Americans face Medicaid exemption hurdles
More Health/Employee Benefits News

Life Insurance News

  • AM Best Affirms Credit Ratings of Fubon Insurance Vietnam Co., Ltd.
  • Three lawsuits put life insurers’ cost-of-insurance practices under scrutiny
  • Military Briefs: November 12-18
  • Security Benefit Series B Preferred Stock Dividend Rate Resets to 10.286%
  • FHLBank Pittsburgh Announces Results in 2026 Board Election
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.